EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐desmoglein‐2 autoantibodies do not discriminate between UK boxer dogs with and without arrhythmogenic right ventricular cardiomyopathy

Chia-Hsuan Chang, Claire Watson, Diptendu Chatterjee, Jade Ward, Kieran Borgeat iD, Hannah Hodgkiss-Geere iD, Joanna Dukes-McEwan iD, Robert Hamilton iD, Melanie J Hezzell iD

Veterinary Record · 28.03.2026 · 198 (7)

DOI: 10.1002/vetr.6014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 06.12.2025. Verfasst von Chia-Hsuan Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Veterinary School, University of Bristol, Langford, UK. Hauptthemen laut MEDLINE: Dog Diseases, Autoantibodies, Arrhythmogenic Right Ventricular Dysplasia, Desmoglein 2. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BSAVA PetSavers (CRP 6.19), The Bristol Veterinary School Research Activity Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence regarding the diagnostic utility of serum anti‐desmoglein‐2 (DSG2) autoantibodies for arrhythmogenic right ventricular cardiomyopathy (ARVC) in boxer dogs is conflicting.

Methods

Prospective standardised evaluation of apparently healthy boxer dogs for ARVC was performed at three referral centres, including blood pressure measurement, electrocardiography, echocardiography, haematology, biochemistry (including cardiac troponin I) and 24‐hour Holter monitoring. Additional dogs with a diagnosis of ARVC were retrospectively recruited. ARVC disease status was defined using cut‐offs of 20 or less (unaffected) and more than 300 (affected) ventricular premature complexes of right ventricular origin in 24 hours. The residual serum samples were stored at ‒80°C for analysis for anti‐DSG2 autoantibodies using ELISA techniques.

Results

Forty boxer dogs were enrolled (11 healthy controls, 10 with preclinical ARVC and 19 with clinical ARVC). Serum anti‐DSG2 autoantibodies were detected in all dogs, bar one healthy dog. DSG2 differed significantly between groups ( p = 0.031) and was significantly lower in dogs with preclinical versus clinical ARVC ( p = 0.025).

Limitations

Some data were collected retrospectively, and some dogs were receiving antiarrhythmic therapy.

Conclusion

Serum DSG2 autoantibodies can be present in boxer dogs with preclinical and clinical ARVC and apparently healthy controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesAutoantibodiesArrhythmogenic Right Ventricular DysplasiaDesmoglein 2AnimalsDogsFemaleMaleProspective StudiesCase-Control StudiesRetrospective StudiesDiagnosis, Differential

Stichwörter der Autor:innen

arrhythmiasbiomarkerscardiologycardiomyopathiescardiovascular diseases

Substanzen

AutoantibodiesDesmoglein 2

Autor:innen und Institutionen

  • Bristol Veterinary School, University of Bristol, Langford, UK.
  • Langford Vets, University of Bristol, Langford, UK.
  • Labatt Family Heart Centre, The Hospital for Sick Children & Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Department of Small Animal Clinical Science, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Neston, UK.

ORCID-Profile: Kieran Borgeat, Hannah Hodgkiss-Geere, Joanna Dukes-McEwan, Robert Hamilton, Melanie J Hezzell

Förderung

  • BSAVA PetSavers (CRP 6.19)
  • The Bristol Veterinary School Research Activity Fund

Zitieren

APA

Chang, C. H., Watson, C., Chatterjee, D., Ward, J., Borgeat, K., Hodgkiss-Geere, H., Dukes-McEwan, J., Hamilton, R., & Hezzell, M. J. (2026). Anti‐desmoglein‐2 autoantibodies do not discriminate between UK boxer dogs with and without arrhythmogenic right ventricular cardiomyopathy. Veterinary Record, 198(7). https://doi.org/10.1002/vetr.6014

Vancouver

Chang CH, Watson C, Chatterjee D, Ward J, Borgeat K, Hodgkiss-Geere H, et al. Anti‐desmoglein‐2 autoantibodies do not discriminate between UK boxer dogs with and without arrhythmogenic right ventricular cardiomyopathy. Veterinary Record. 2026;198(7). doi:10.1002/vetr.6014

BibTeX
@article{Chang2026,
  author = {Chang, Chia-Hsuan and Watson, Claire and Chatterjee, Diptendu and Ward, Jade and Borgeat, Kieran and Hodgkiss-Geere, Hannah and Dukes-McEwan, Joanna and Hamilton, Robert and Hezzell, Melanie J},
  title = {Anti‐desmoglein‐2 autoantibodies do not discriminate between UK boxer dogs with and without arrhythmogenic right ventricular cardiomyopathy},
  journal = {Veterinary Record},
  year = {2026},
  volume = {198},
  number = {7},
  doi = {10.1002/vetr.6014}
}
Kostenlos starten →